Deal Announcements

CytoPherx Closes $5 Million Venture Capital Funding

Tuesday, June 22, 2010 5:31:00 AM PDT | VentureDeal Staff

Ann Arbor, Michigan  --  Medical device company CytoPherx has raised $5 million in new venture capital investment.

CytoPherx is a clinical stage medical device company that is focused on finding treatments for inflammation-based diseases and conditions.

Investors in the round were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1